Concepedia

Publication | Open Access

Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First-Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study

DOIFull Paper Access

88

Citations

9

References

2012

Year

Javier Sastre, M.L. Maestro, Auxiliadora Gómez‐España, Fernando Rivera, Manuel Valladares, Bartomeu Massutí, Manuel Benavides, Manuel Gallén, Eugenio Marcuello, Albert Abad,
The Oncologist

Abstract

The CTC count is a strong prognostic factor for PFS and OS outcomes in metastatic colorectal cancer patients.

References

YearCitations

Page 1